The Clinical Cost of a Cheaper Plaster: Gypsona vs. Benecast in the Treatment of Childhood Forearm Fractures
The Internet Journal of Hand Surgery · 2009
DOI: 10.5580/2604 ↗At a glance
Journal article in The Internet Journal of Hand Surgery, 2009.
Abstract (original language)
There are many plaster-of-Paris products on the market, of which Gypsona® Bp (BSN Medical Ltd.) and Benecast POP (Benefoot UK Ltd.) are two. Both are used in the United Kingdom in the National Health Service with little evidence base between the two. Financial restraint can put pressure on orthopaedic departments to change plaster products, and without evidence base there is little to prevent less quality products being used, possibly resulting in poorer outcomes. We have performed a retrospective study comparing their use in regards to childhood forearm fractures. In this study we used the final fracture angulation as the clinical endpoint of interest. For the greenstick fracture type there was a very statistically significant difference in the resulting fracture angulation between Gypsona and Benecast, Benecast being much greater (p value > 0.01). We feel that Benecast was inferior in regards to holding reduction as compared to Gypsona for childhood forearm fractures.
Cite
APA
(2009). The Clinical Cost of a Cheaper Plaster: Gypsona vs. Benecast in the Treatment of Childhood Forearm Fractures. The Internet Journal of Hand Surgery. https://doi.org/10.5580/2604
Vancouver
The Clinical Cost of a Cheaper Plaster: Gypsona vs. Benecast in the Treatment of Childhood Forearm Fractures. The Internet Journal of Hand Surgery. 2009. doi:10.5580/2604
BibTeX
@article{euvimed2009,
title = {The Clinical Cost of a Cheaper Plaster: Gypsona vs. Benecast in the Treatment of Childhood Forearm Fractures},
journal = {The Internet Journal of Hand Surgery},
year = {2009},
doi = {10.5580/2604}
}
EUVIMED